跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Philippines FDA
/
Mixtard 30 Flexpen
Approved
STANDARD
Mixtard 30 Flexpen
Novo Nordisk Produção Farmacêutica do Brasil Ltda.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
605e5a73b426c255
Company
Novo Nordisk Produção Farmacêutica do Brasil Ltda.
Type
Standard
Approval Details
Approval Id
605e5a73b426c255
Drug Approval Philippines Name
Mixtard 30 Flexpen
Product Name
Mixtard 30 Flexpen
Registration Number
BR-1371
Brand Name
Mixtard 30 Flexpen
Generic Name
Insulin Human (rDNA)
Dosage Form
Suspension for Injection (SC) (30% Soluble Insulin and 70% Isophane Insulin)
Dosage Strength
100 U/mL
Manufacturer
Novo Nordisk Produção Farmacêutica do Brasil Ltda.
Importer
Novo Nordisk Pharmaceuticals (Philippines), Inc.
Distributor
Novo Nordisk Pharmaceuticals (Philippines), Inc.
Issuance Date
24 September 2021
Expiry Date
24 September 2026
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
605e5a73b426c255
Type
Standard
Back to Philippines FDA Approvals
Mixtard 30 Flexpen - Philippines FDA Drug Approval Details